Expressing support for the designation of April as "Co-Occurring Disorders Awareness Month".

Bill 118 HRES 1165, also known as the "Co-Occurring Disorders Awareness Month" bill, is a piece of legislation that aims to express support for the designation of April as a month dedicated to raising awareness about co-occurring disorders. Co-occurring disorders, also known as dual diagnosis, refer to the presence of both a mental health disorder and a substance use disorder in an individual.

The bill highlights the importance of recognizing and addressing co-occurring disorders, as individuals with these conditions often face unique challenges in accessing appropriate treatment and support. By designating April as "Co-Occurring Disorders Awareness Month," the bill seeks to increase public awareness about the prevalence of these disorders and the need for integrated treatment approaches.

The legislation emphasizes the importance of promoting collaboration among mental health and substance use disorder treatment providers, as well as the need for increased funding and resources to support individuals with co-occurring disorders. Additionally, the bill calls for increased research and data collection to better understand the impact of co-occurring disorders and improve outcomes for affected individuals. Overall, Bill 118 HRES 1165 aims to raise awareness about co-occurring disorders and advocate for improved access to comprehensive, integrated treatment for individuals facing these complex conditions. By supporting the designation of April as "Co-Occurring Disorders Awareness Month," the bill seeks to promote understanding, compassion, and support for individuals living with co-occurring disorders in the United States.